Recurrent cervical cancer detection using DNA methylation markers in self‐collected samples from home
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35143 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Mirte Schaafsma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Net…. Hauptthemen laut MEDLINE: DNA Methylation, Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, DNA, Viral. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Early detection of recurrent cervical cancer is important to improve survival rates. The aim of this study was to explore the clinical performance of DNA methylation markers and high‐risk human papillomavirus (HPV) in cervicovaginal self‐samples and urine for the detection of recurrent cervical cancer. Cervical cancer patients without recurrence ( n = 47) collected cervicovaginal self‐samples and urine pre‐ and posttreatment. Additionally, 20 patients with recurrent cervical cancer collected cervicovaginal self‐samples and urine at time of recurrence. All samples were self‐collected at home and tested for DNA methylation and high‐risk HPV DNA by PCR. In patients without recurrent cervical cancer, DNA methylation levels decreased 2‐years posttreatment compared to pretreatment in cervicovaginal self‐samples ( p < .0001) and urine ( p < .0001). DNA methylation positivity in cervicovaginal self‐samples was more frequently observed in patients with recurrence (77.8%) than in patients without recurrence 2‐years posttreatment (25.5%; p = .0004). Also in urine, DNA methylation positivity was more frequently observed in patients with recurrence (65%) compared to those without recurrence (35.6%; p = .038). Similarly, high‐risk HPV positivity in both cervicovaginal self‐samples and urine was more frequent (52.6% and 55%, respectively) in patients with recurrence compared to patients without recurrence (14.9% and 8.5%, respectively) ( p = .004 and p = .0001). In conclusion, this study shows the potential of posttreatment monitoring of cervical cancer patients for recurrence by DNA methylation and high‐risk HPV testing in cervicovaginal and urine samples collected at home. The highest recurrence detection rate was achieved by DNA methylation testing in cervicovaginal self‐samples, detecting 77.8% of all recurrences and, specifically, 100% of the local recurrences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands.
- Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Biomarkers and Imaging, Cancer Center Amsterdam, Amsterdam, The Netherlands.
- Department of Gynecology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
- Department of Gynecology, Zaans Medisch Centrum, Zaandam, The Netherlands.
- Department of Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: Mirte Schaafsma, Rianne van den Helder, Constantijne H Mom, Renske D M Steenbergen, Maaike C G Bleeker, Nienke E van Trommel
Zitieren
APA
Schaafsma, M., van den Helder, R., Mom, C. H., Steenbergen, R. D. M., Bleeker, M. C. G., & van Trommel, N. E. (2025). Recurrent cervical cancer detection using DNA methylation markers in self‐collected samples from home. International Journal of Cancer. https://doi.org/10.1002/ijc.35143
Vancouver
Schaafsma M, van den Helder R, Mom CH, Steenbergen RDM, Bleeker MCG, van Trommel NE. Recurrent cervical cancer detection using DNA methylation markers in self‐collected samples from home. International Journal of Cancer. 2025. doi:10.1002/ijc.35143
BibTeX
@article{Schaafsma2025,
author = {Schaafsma, Mirte and van den Helder, Rianne and Mom, Constantijne H and Steenbergen, Renske D M and Bleeker, Maaike C G and van Trommel, Nienke E},
title = {Recurrent cervical cancer detection using DNA methylation markers in self‐collected samples from home},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35143}
}
EUVIMED